-
Abstract Number: 1576
New Patient-Reported Outcome Measures for Early Systemic Sclerosis Using the FDA Guidance on Patient Reported Outcome Measures
-
Abstract Number: 1577
Elevated Neutrophil Extracellular Traps in Systemic Sclerosis-associated Vasculopathy and Suppression by a Synthetic Prostacyclin Analog
-
Abstract Number: 1578
Association of Systemic Sclerosis and Other Systemic Autoimmune Disease Diagnosis with Increasing Anti-RNA Polymerase III Antibodies
-
Abstract Number: 1579
Exploring the Cardiovascular Complications of Pulmonary Arterial Hypertension in Individuals with Systemic Sclerosis
-
Abstract Number: 1580
Overt Polyautoimmunity and Its Risk Factors in a Multicenter Cohort of Systemic Sclerosis Patients
-
Abstract Number: 1581
Neutrophil-to- lymphocyte Ratio: A Possible Biomarker for Clinical Response After Autologous Hematopoietic Stem Cell Transplantation
-
Abstract Number: 1582
Impact of Immunosuppressive Treatment on Development and Survival in Systemic Sclerosis Associated Pulmonary Arterial Hypertension (SSc-PAH)
-
Abstract Number: 1583
The Association of Weakpositive Anti-RNA Polymerase III Antibodies with the Diagnosis and Complications of Systemic Sclerosis and Other Systemic Autoimmune Diseases
-
Abstract Number: 1584
Efficacy of Tofacitinib in the Treatment of Early Diffuse Cutaneous Systemic Sclerosis: A Clinical Study in Bangladesh
-
Abstract Number: 1585
Characterization of the Fecal Metabolome in Early Systemic Sclerosis
-
Abstract Number: 1586
The Relationship Between the Presence, Quantity and Distribution of Cutaneous Telangiectasia and Other Vascular Manifestations of Systemic Sclerosis
-
Abstract Number: 1587
Predictors of Body Mass Index in an Early Systemic Sclerosis Cohort
-
Abstract Number: 1588
Validation of a Lung Ultrasound Interpretation Criteria for Interstitial Lung Disease Screening in Systemic Sclerosis and Inflammatory Myopathy
-
Abstract Number: 1589
Whole Skin Gene Expression Analysis Identifies Discrete Modules That Differentiate Antinuclear Antibody Subsets in Systemic Sclerosis
-
Abstract Number: 1590
Milder ILD with Preserved Lung Function Significantly Contributes to Respiratory Caused Mortality in SSc
- « Previous Page
- 1
- …
- 105
- 106
- 107
- 108
- 109
- …
- 181
- Next Page »